These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20849659)

  • 21. The effect of a multispecies probiotic on microbiota composition in a clinical trial of patients with diarrhea-predominant irritable bowel syndrome.
    Hod K; Dekel R; Aviv Cohen N; Sperber A; Ron Y; Boaz M; Berliner S; Maharshak N
    Neurogastroenterol Motil; 2018 Dec; 30(12):e13456. PubMed ID: 30136337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotic bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 versus placebo for the symptoms of bloating in patients with functional bowel disorders: a double-blind study.
    Ringel-Kulka T; Palsson OS; Maier D; Carroll I; Galanko JA; Leyer G; Ringel Y
    J Clin Gastroenterol; 2011 Jul; 45(6):518-25. PubMed ID: 21436726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR.
    Malinen E; Rinttilä T; Kajander K; Mättö J; Kassinen A; Krogius L; Saarela M; Korpela R; Palva A
    Am J Gastroenterol; 2005 Feb; 100(2):373-82. PubMed ID: 15667495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation.
    Mezzasalma V; Manfrini E; Ferri E; Sandionigi A; La Ferla B; Schiano I; Michelotti A; Nobile V; Labra M; Di Gennaro P
    Biomed Res Int; 2016; 2016():4740907. PubMed ID: 27595104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome.
    Giamarellos-Bourboulis E; Tang J; Pyleris E; Pistiki A; Barbatzas C; Brown J; Lee CC; Harkins TT; Kim G; Weitsman S; Barlow GM; Funari VA; Pimentel M
    Scand J Gastroenterol; 2015; 50(9):1076-87. PubMed ID: 25865706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota associations with diet in irritable bowel syndrome and the effect of low FODMAP diet and probiotics.
    Staudacher HM; Scholz M; Lomer MC; Ralph FS; Irving PM; Lindsay JO; Fava F; Tuohy K; Whelan K
    Clin Nutr; 2021 Apr; 40(4):1861-1870. PubMed ID: 33183883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, double-blinded, placebo-controlled clinical trial on Lactobacillus-containing cultured milk drink as adjuvant therapy for depression in irritable bowel syndrome.
    Sarkawi M; Raja Ali RA; Abdul Wahab N; Abdul Rathi ND; Mokhtar NM
    Sci Rep; 2024 Apr; 14(1):9478. PubMed ID: 38658619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.
    Hatakka K; Mutanen M; Holma R; Saxelin M; Korpela R
    J Am Coll Nutr; 2008 Aug; 27(4):441-7. PubMed ID: 18978162
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use.
    Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S; Jonkers DM; Koning CJ; Kruimel JW; Mulder L; van der Vaart IB; Conchillo JM; Masclee AA
    Neurogastroenterol Motil; 2014 May; 26(5):705-14. PubMed ID: 24588932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
    Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
    Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria.
    Maukonen J; Satokari R; Mättö J; Söderlund H; Mattila-Sandholm T; Saarela M
    J Med Microbiol; 2006 May; 55(Pt 5):625-633. PubMed ID: 16585652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of new probiotics by strain combinations: is it possible to improve the adhesion to intestinal mucus?
    Collado MC; Meriluoto J; Salminen S
    J Dairy Sci; 2007 Jun; 90(6):2710-6. PubMed ID: 17517710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of
    Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
    Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
    Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Persistence of probiotic strains in the gastrointestinal tract when administered as capsules, yoghurt, or cheese.
    Saxelin M; Lassig A; Karjalainen H; Tynkkynen S; Surakka A; Vapaatalo H; Järvenpää S; Korpela R; Mutanen M; Hatakka K
    Int J Food Microbiol; 2010 Dec; 144(2):293-300. PubMed ID: 21074284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbial community and metabolomic comparison of irritable bowel syndrome faeces.
    Ponnusamy K; Choi JN; Kim J; Lee SY; Lee CH
    J Med Microbiol; 2011 Jun; 60(Pt 6):817-827. PubMed ID: 21330412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.